Revision history of "Everolimus plus octreotide long-acting repeatable in patients with colorectal neuroendocrine tumors: a subgroup analysis of the phase III RADIANT-2 study" (Q36565634)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

14 May 2022

26 October 2021

6 May 2021

13 January 2020

24 June 2019

2 February 2019

7 December 2018

21 September 2018

2 July 2018

17 December 2017

30 September 2017

8 September 2017

15 August 2017